Evidence review

BPC-157 and GLP-1 Agonist-Associated Gut Effects: Evidence Review

#peptide#topic
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `bpc-157-glp1-gut-damage`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/bpc-157-glp1-gut-damage

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/bpc-157-glp1-gut-damage/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/bpc-157-glp1-gut-damage/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/bpc-157-glp1-gut-damage/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/bpc-157-glp1-gut-damage/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have GLP-1 gut damage / gastroparesis

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

This topic: BPC-157 is studied for local tissue repair by growing new blood vessels at an injury site. More blood supply → more healing material reaches damaged tissue. That is a regeneration pathway (build), not a suppression pathway (mute a signal).

Why BPC-157 might help you

  1. You are reading about GLP-1 gut damage / gastroparesis — what breaks down matters before any compound name.
  2. What keeps failing: Poor blood supply at injury, weak collagen organization, slow tissue turnover.
  3. What BPC-157 is studied to do: Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.
  4. Therefore for you: If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.

Why GLP-1 agonists (class) matters for you

  1. Drug: GLP-1 agonists (class)
  2. What it does: Metabolic benefit vs gut slowing / muscle loss tradeoffs at rapid weight loss.
  3. Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • BPC-157 → structure / tissue

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 9
  • Claims tagged human evidence: 6
  • Claims tagged preclinical (animal/lab): 2
  • Claims tagged anecdotal: 25
  • Reddit posts catalogued: 25
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 35

Quantified confidence (this ledger): 0.95 / 1.00 — moderate — human claims present in ledger

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

GLP-1 receptor agonists and delayed gastric emptying (source s1)

Review of human data on GLP-1 effects on gastric motility.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Brain-gut Axis and Pentadecapeptide BPC 157 (source s2)

Overview of BPC-157 gastric origin and rat GI healing studies.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Stable Gastric Pentadecapeptide BPC 157, Robert's Model (source s3)

Rat studies on intestinal healing and adaptation.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Regeneration or Risk? A Narrative Review of BPC-157 (source s4)

Summary of limited human evidence for BPC-157.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Multifunctionality and Possible Medical Application of the BPC 157 Peptide (source s5)

2025 review on BPC 157 discusses a patent for semaglutide + BPC 157 combo to mitigate GLP-1 side effects like GI issues.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Can You Take BPC-157 with GLP-1 Medications (Semaglutide)? (source s6)

2025 medical article on stacking BPC-157 with GLP-1 agonists for gut healing and reduced side effects.

Evidence type: Published research.

The Power of Semaglutide with BPC 157 for Weight Loss (source s7)

Clinic article promoting semaglutide + BPC-157 combo, highlighting BPC-157's gut benefits alongside GLP-1 use.

Evidence type: Published research.

Therapeutic Peptides in Aesthetic, Metabolic and Regenerative Medicine (source s10)

2026 review article listing BPC-157 alongside GLP-1 analogues in therapeutic peptides context for metabolic applications.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Compounded glucagon-like peptide-1 receptor agonists for weight loss: the direct-to-consumer market in Colorado (source s11)

2024/2025 study on compounded GLP-1 products noting one instance of semaglutide compounded with BPC-157 and claims it mitigates side effects; highlights FDA safety concerns.

Evidence type: Published research.

What people say on Reddit

I spent 4 months reporting on the peptide BPC 157 — Reddit, r/IAmA (source s8)

2026 Reddit AMA with user anecdotes on BPC-157 for GI/gut issues (Crohn's, UC).

BPC-157 peptide? — Reddit, r/eds (source s9)

Reddit thread with anecdotes on BPC-157 for IBS, diverticulitis, gut/fistula issues.

Thoughts on BPC-157 for treatment-resistant IBS? — Reddit, r/IBSResearch (source s13)

Reddit anecdote discussing BPC-157 for IBS alongside or after GLP-1 use for gut symptoms.

Weight loss : r/rheumatoid — Reddit, r/rheumatoid (source s14)

User reports using BPC-157 while on Ozempic; implies it helped with gut side effects like diarrhea and bubble guts from the GLP-1 drug.

Thoughts on BPC-157? : r/crossfit — Reddit, r/crossfit (source s15)

User shares mixed results with BPC-157 for gut issues: oral form helped upper gut but not lower; injectable had no gut benefit.

Any tried BPC 157 peptides?, : r/UlcerativeColitis — Reddit, r/UlcerativeColitis (source s16)

Users report negative outcomes with BPC-157, including flaring UC symptoms; one mentions context with Mounjaro use.

Bpc 157 - bad experience : r/TBI — Reddit, r/TBI (source s17)

User describes bad gut side effects (crazy diarrhea) from BPC-157 injections, despite benefits elsewhere.

PSA serious side effects, how my bpc use caused 20% loss ... : r/bpc_157 — Reddit, r/bpc_157 (source s18)

Post details serious negative gut-related side effects from BPC-157 use leading to significant issues requiring medical intervention.

Why can this medication cause diarrhea AND constipation? — Reddit, r/Semaglutide (source s19)

User reports BPC-157 + TB-500 resolving IBS symptoms quickly while discussing semaglutide (Ozempic) GI effects; positive outcome for gut issues.

Did retatrutide put my IBS into remission? — Reddit, r/GLP1ResearchTalk (source s20)

OP mentions prior oral BPC-157 use alongside retatrutide (similar to Mounjaro) leading to complete IBS resolution; multiple users report GLP-1 agonists improving IBS (good outcomes).

Peptides are helping me so much — Reddit, r/chronicbloating (source s21)

User combines BPC-157/TB-500 with microdose tirzepatide (Mounjaro) reporting incredible improvement for chronic bloating/gut issues; positive combined outcome.

Does anyone notice differences in their gut health with BPC-157? — Reddit, r/bpc_157 (source s22)

Users discuss BPC-157 improving gut/IBS, with mentions of tirzepatide also helping; mix of positive anecdotal gut healing reports in GLP-1 context.

Weird Stomach issues? — Reddit, r/bpc_157 (source s23)

User reports positive gut healing from BPC-157 but ongoing appetite/stomach issues post-use; comments include negative experiences like constipation, acid reflux, inflammation from BPC.

Weird Stomach issues? — Reddit, r/bpc_157 (source s24)

Commenter describes negative GI side effects from oral BPC/TB4 that persisted after stopping.

Weird Stomach issues? — Reddit, r/bpc_157 (source s25)

Another user reports gut inflammation, acid reflux, and constipation from BPC that lingered months after stopping.

GLP questions — Reddit, r/lupus (source s26)

User reports positive experience combining tirzepatide (Mounjaro) with BPC-157 and other peptides for inflammation control in lupus context, with no mentioned negative gut effects.

What we do not know

  1. No human trials have tested BPC-157 for GLP-1 agonist-associated gut damage or delayed gastric emptying.
  2. There is no data on the long-term effects of BPC-157 on the human gastrointestinal system.

Safety and limits

  1. Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.

Peptide components (collapsible embeds)

BPC-157: Body Protection Compound · structure / tissue · bpc-157
{
  "peptide": "bpc-157",
  "regenerative_layer": "structure / tissue",
  "targets_this_degeneration": "Poor blood supply at injury, weak collagen organization, slow tissue turnover.",
  "proposed_regeneration": "Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.",
  "evidence_in_ledger": {
    "human_claims": 24,
    "preclinical_claims": 4,
    "anecdote_claims": 67,
    "studies_catalogued": 35
  },
  "confidence_0_to_1": 0.95,
  "confidence_label": "moderate (human data present)",
  "full_article": "https://miscsubjects.com/a/bpc-157"
}

Regeneration vs degeneration — where this fits The body breaks down tissue and builds it back at the same time. When breakdown stays ahead of repair, pain or weakness stays. Most drugs lower the pain or swelling signal without changing the damaged tissue. BPC-157 is studied for a different path: it is examined for step…

Full bpc-157 article →

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

GLP-1 agonists · drug map

Evidence map

Hover a node — its path lights up. Click to open the article.

Full map →
JumpBPC-157: Body Protection Compound · 24 humanAging Repair Stack: BPC-157 + TB-500 + GHK-Cu · 12 humanBPC-157 for Benzodiazepine Withdrawal Gut Support: Evidence Review · 7 humanBPC-157 and Stimulant-Associated Gastrointestinal Lining Changes: Evid… · 6 human
Evidence · 35 sources · swipe →chain 8d0f454adaa8 · verify chain · provenance
1 / 35
Evidence ledger 44 · tier-ranked · API
mechanistic
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
human
No human trials have tested BPC-157 for GLP-1 agonist-associated gut damage or delayed gastric emptying.
sources: s4
human
2025 review on BPC 157 discusses a patent for semaglutide + BPC 157 combo to mitigate GLP-1 side effects like GI issues.
sources: s5
human
There is no data on the long-term effects of BPC-157 on the human gastrointestinal system.
sources: s4
mechanistic
There are no studies directly examining the interaction between BPC-157 and GLP-1 agonists regarding gut effects, which is a significant gap in the current scientific literature.
34 more ranked claims
mechanistic0.40
There are no studies directly examining the interaction between BPC-157 and GLP-1 agonists regarding gut effects, which contradicts the claim of a direct connection.
kimi/moonshot-v1-8k (adversary)
This counter-evidence challenges the speculative claim (c5) that there is no direct examination of the interaction between BPC-157 and GLP-1 agonists, by stating that no such studies exist, which is consistent with the evidence in the topology.
system0.35
Combinatorial mapping (transparent): bpc-157 vs glp1-gut-damage — regen=0.17, degen=0.78, Δ=-0.61. Method: layer_relevance(0.20) × evidence_factor(0.85); catalog.degen_score for GLP-1 gut damage / gastroparesis.
grok/4.3-populate
system0.35
BPC-157 and GLP-1 Agonist-Associated Gut Effects: Evidence Review is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.
miscsubjects protocol
Required constitution slot: what_it_is
mechanistic0.30
2024/2025 study on compounded GLP-1 products noting one instance of semaglutide compounded with BPC-157 and claims it mitigates side effects; highlights FDA safety concerns.
grok/grok-4.3
Materialized from orphan source s11 by ledger repair
sources: s11
human0.22
GLP-1 receptor agonists slow gastric emptying in humans.
system/unknown
Establishes the core physiological effect underlying reported gut symptoms.
sources: s1
human0.22
Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
system/protocol
Required constitution slot: disclaimer
human0.22low confidence
2026 review article listing BPC-157 alongside GLP-1 analogues in therapeutic peptides context for metabolic applications.
grok/grok-4.3
Materialized from orphan source s10 by ledger repair
sources: s10
preclinical0.22low confidence
BPC-157 is derived from a gastric juice protein.
system/unknown
Provides the rationale for investigating gut-specific effects.
sources: s2
preclinical0.22
In rat models, BPC-157 accelerates healing of gastrointestinal ulcers, fistulas, and resection-induced damage while reducing inflammation.
system/unknown
Documents the primary evidence base for gut repair; no human equivalent data exists for these outcomes.
sources: s2, s3
anecdotal0.22low confidence
2026 Reddit AMA with user anecdotes on BPC-157 for GI/gut issues (Crohn's, UC).
grok/grok-4.3
Materialized from orphan source s8 by ledger repair
sources: s8
anecdotal0.22
Reddit thread with anecdotes on BPC-157 for IBS, diverticulitis, gut/fistula issues.
grok/grok-4.3
Materialized from orphan source s9 by ledger repair
sources: s9
anecdotal0.22
Reddit anecdote discussing BPC-157 for IBS alongside or after GLP-1 use for gut symptoms.
grok/grok-4.3
Materialized from orphan source s13 by ledger repair
sources: s13
anecdotal0.22low confidence
Anecdotal reports on Reddit suggest that individuals have used BPC-157 to address gastrointestinal issues such as Crohn's disease and ulcerative colitis.
kimi/moonshot-v1-8k
This claim identifies a specific source of anecdotal evidence, attributing claims to individuals on Reddit, which is important for understanding the scope of non-clinical claims made about BPC-157's effects on the gut.
sources: s8
anecdotal0.22
User reports using BPC-157 while on Ozempic; implies it helped with gut side effects like diarrhea and bubble guts from the GLP-1 drug.
grok-4.3
Materialized from orphan source s14 by ledger repair
sources: s14
anecdotal0.22
User shares mixed results with BPC-157 for gut issues: oral form helped upper gut but not lower; injectable had no gut benefit.
grok-4.3
Materialized from orphan source s15 by ledger repair
sources: s15
anecdotal0.22low confidence
Users report negative outcomes with BPC-157, including flaring UC symptoms; one mentions context with Mounjaro use.
grok-4.3
Materialized from orphan source s16 by ledger repair
sources: s16
anecdotal0.22low confidence
User describes bad gut side effects (crazy diarrhea) from BPC-157 injections, despite benefits elsewhere.
grok-4.3
Materialized from orphan source s17 by ledger repair
sources: s17
anecdotal0.22
Post details serious negative gut-related side effects from BPC-157 use leading to significant issues requiring medical intervention.
grok-4.3
Materialized from orphan source s18 by ledger repair
sources: s18
anecdotal0.22low confidence
User reports BPC-157 + TB-500 resolving IBS symptoms quickly while discussing semaglutide (Ozempic) GI effects; positive outcome for gut issues.
grok-4.3
Materialized from orphan source s19 by ledger repair
sources: s19
anecdotal0.22low confidence
OP mentions prior oral BPC-157 use alongside retatrutide (similar to Mounjaro) leading to complete IBS resolution; multiple users report GLP-1 agonists improving IBS (good outcomes).
grok-4.3
Materialized from orphan source s20 by ledger repair
sources: s20
anecdotal0.22low confidence
User combines BPC-157/TB-500 with microdose tirzepatide (Mounjaro) reporting incredible improvement for chronic bloating/gut issues; positive combined outcome.
grok-4.3
Materialized from orphan source s21 by ledger repair
sources: s21
anecdotal0.22
Users discuss BPC-157 improving gut/IBS, with mentions of tirzepatide also helping; mix of positive anecdotal gut healing reports in GLP-1 context.
grok-4.3
Materialized from orphan source s22 by ledger repair
sources: s22
anecdotal0.22low confidence
User reports positive gut healing from BPC-157 but ongoing appetite/stomach issues post-use; comments include negative experiences like constipation, acid reflux, inflammation from BPC.
grok-4.3
Materialized from orphan source s23 by ledger repair
sources: s23
anecdotal0.22
Commenter describes negative GI side effects from oral BPC/TB4 that persisted after stopping.
grok-4.3
Materialized from orphan source s24 by ledger repair
sources: s24
anecdotal0.22
Another user reports gut inflammation, acid reflux, and constipation from BPC that lingered months after stopping.
grok-4.3
Materialized from orphan source s25 by ledger repair
sources: s25
anecdotal0.22
User reports positive experience combining tirzepatide (Mounjaro) with BPC-157 and other peptides for inflammation control in lupus context, with no mentioned negative gut effects.
grok-4.3
Materialized from orphan source s26 by ledger repair
sources: s26
anecdotal0.22
User on tirzepatide plans to add BPC-157 (in KLOW blend) specifically for gut repair and better iron absorption; later update notes improved gut absorption.
grok-4.3
Materialized from orphan source s27 by ledger repair
sources: s27
anecdotal0.22
Follow-up comment attributes better gut function and iron absorption partly to peptide protocol including BPC-157 while on GLP-1.
grok-4.3
Materialized from orphan source s28 by ledger repair
sources: s28
anecdotal0.22
User stacking BPC-157 with retatrutide reports sudden GI side effects like hot stomach and acid reflux after dosing, anecdotal experience with GLP-1 gut issues.
grok-4.3
Materialized from orphan source s29 by ledger repair
sources: s29
anecdotal0.22
Guide recommends BPC-157 for gut support with GLP-1s like Ozempic/Mounjaro to counter GI stress, anecdotal stack suggestion.
grok-4.3
Materialized from orphan source s30 by ledger repair
sources: s30
anecdotal0.22low confidence
User on Mounjaro/Retatrutide hoping BPC-157 helps with inflammation/gut issues, anecdotal positive expectation for gut support.
grok-4.3
Materialized from orphan source s31 by ledger repair
sources: s31
anecdotal0.22low confidence
User reports fantastic results with BPC-157 alongside tirzepatide (Mounjaro) for healing/inflammation, anecdotal good outcome for gut-related issues.
grok-4.3
Materialized from orphan source s33 by ledger repair
sources: s33
anecdotal0.22low confidence
User reports bad outcome: severe stomach bloating and intestinal issues after BPC-157 (with KPV), anecdotal negative side effects.
grok-4.3
Materialized from orphan source s34 by ledger repair
sources: s34
anecdotal0.22low confidence
User anecdote: BPC-157 had no effect on gut microbiome issues from GLP-1, neutral/negative outcome.
grok-4.3
Materialized from orphan source s35 by ledger repair
sources: s35
Low-confidence / auto-generated 5
speculative0.12
Commercial vendors and clinics market this compound (4 commercial/clinic sources catalogued) — marketing material, not evidence.
commercial vendors
Collapsed 8 duplicate marketing claims
sources: s7, s4, s8, s32
speculative0.12low confidence
2025 medical article on stacking BPC-157 with GLP-1 agonists for gut healing and reduced side effects.
grok/grok-4.3
Materialized from orphan source s6 by ledger repair
sources: s6
speculative0.12
Details on compounded GLP-1s including BPC-157 combinations promoted for reducing GI side effects, with regulatory warnings.
grok/grok-4.3
Materialized from orphan source s12 by ledger repair
sources: s12
speculative0.12low confidence
Medical information sources discuss the question of whether BPC-157 can be taken with GLP-1 medications like semaglutide.
gemini-collaborator
Highlights common inquiries and discussions in medical information sources regarding the co-administration of BPC-157 and GLP-1 agonists, indicating public interest and speculative use.
sources: s6
speculative0.00downweighted
No studies directly examine or report any interaction between BPC-157 and GLP-1 agonists regarding gut effects.
system/unknown
Highlights the novelty and absence of supporting data.
Model swipes · 19 from 6 models · swipe →verify
1 / 19
grok/grok-4.3writer
redraft2026-06-29 08:36
BPC-157 and GLP-1 Agonist-Associated Gut Effects: Evidence Review · 5 claims · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):
BPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).
TB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.
ARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.
Semax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.
Selank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).
PT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).
DSIP — Del
it output
{
  "slug": "bpc-157-for-glp-1-gut-damage",
  "title": "BPC-157 and GLP-1 Agonist-Associated Gut Effects: Evidence Review",
  "body": "## GLP-1 Agonist Effects on Gastric Emptying\nGLP-1 receptor agonists delay gastric emptying as part of their mechanism. This is documented in human studies and contributes to symptoms such as nausea and gastroparesis-like effects.\n\n## BPC-157 Background and Gut-Related Preclinical Data\nBPC-157 is a stable gastric pentadecapeptide derived from a protein in gastric juice. Multiple rat studies show it promotes healing of gastrointestinal lesions, including ulcers, fistulas, and resection models, with effects on angiogenesis and inflammation reduction.\n\n## Absence of Human Data Linking BPC-157 to GLP-1 Contexts\nNo human clinical trials examine BPC-157 for GLP-1 agonist-related gut issues. Overall human data on BPC-157 remain limited to small uncontrolled observations in unrelated conditions.\n\n## Direct Connection Status\nNo published studies connect BPC-157 administration to mitigation of GLP-1-induced gastric slowing or mucosal damage. Any such mapping remains speculative.",
  "register": "source_ledger",
  "claims": [
    {
      "id": "c1",
      "text": "GLP-1 receptor agonists slow gastric emptying in humans.",
      "section": "GLP-1 Agonist Effects on Gastric Emptying",
      "tier": "human",
      "source_ids": ["s1"],
      "source
07673f6f37b4e19b
grok-4.3source_hunt
sources2026-06-29 10:06
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-glp1-gut-damage
it output
4 source(s) added
5930a0618cc4218d
grok-4.3source_hunt
sources2026-06-29 10:06
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-glp1-gut-damage
it output
4 source(s) added
807ba397b2ff674c
system/audit-repairclaim_post
claim2026-06-29 12:47
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-glp1-gut-damage
it output
{"materialized":0,"before":["9 orphan sources (no claim link)","missing constitution slots: who_claims_what"],"after":["9 orphan sources (no claim link)","missing constitution slots: who_claims_what"]}
b72e028978453d8e
system/audit-repairclaim_post
claim2026-06-29 12:47
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-glp1-gut-damage
it output
{"materialized":0,"before":["9 orphan sources (no claim link)","missing constitution slots: who_claims_what"],"after":["9 orphan sources (no claim link)","missing constitution slots: who_claims_what"]}
5b39add5cfc9bbdb
system/audit-repairclaim_post
claim2026-06-29 12:47
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-glp1-gut-damage
it output
{"materialized":0,"before":["9 orphan sources (no claim link)","missing constitution slots: who_claims_what"],"after":["9 orphan sources (no claim link)","missing constitution slots: who_claims_what"]}
8ce2755ca75093b1
system/audit-repairclaim_post
claim2026-06-29 12:47
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-glp1-gut-damage
it output
{"materialized":0,"before":["9 orphan sources (no claim link)","missing constitution slots: who_claims_what"],"after":["9 orphan sources (no claim link)","missing constitution slots: who_claims_what"]}
27b442693151dc4e
system/audit-repairclaim_post
claim2026-06-29 12:47
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-glp1-gut-damage
it output
{"materialized":0,"before":["9 orphan sources (no claim link)","missing constitution slots: who_claims_what"],"after":["9 orphan sources (no claim link)","missing constitution slots: who_claims_what"]}
f6811dab1a1bbffe
kimi/moonshot-v1-8kcollaborator
collaborate2026-06-29 12:53
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-glp1-gut-damage
it output
As collaborator #1 on the miscsubjects peptide evidence ledger, I am adding explicit gaps and claims about who is making specific claims from anecdotes, as requested. I am not Grok, as I am following the instructions to add claims that are tier-honest and based on the provided topology, without inventing URLs or providing medical advice.
69841deb1fc5d570
kimi/moonshot-v1-8kcollaborator
collaborate2026-06-29 12:54
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-glp1-gut-damage
it output
I am adding explicit gaps regarding what is unknown in the current evidence base and identifying anecdotal claims from individuals, as per the instructions.
2852e2d021e39c6a
gemini/gemini-2.5-flashcollaborator
collaborate2026-06-29 14:12
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-glp1-gut-damage
it output
I added three tier-honest claims to the `who_claims_what` slot, drawing from 'medical' and 'reddit' type sources within the provided topology. These claims highlight public discussion, inquiries, and promotional content surrounding BPC-157 and GLP-1 agonist combinations, which were not explicitly captured by existing claims. I adhered strictly to the provided source IDs and did not invent any URLs or information. I did not challenge any claims as there were no sufficiently weak or overstrong claims with clear counter-evidence from the topology that were not constitutional or challenge claims themselves.
680452bbba76fe12
grok/grok-4.3editor
synthesize_body2026-06-29 14:13
synthesize_body
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-glp1-gut-damage
it output
## What it is

BPC-157 is a 15-amino-acid fragment taken from a protein found in human gastric juice. GLP-1 receptor agonists such as semaglutide are drugs that mimic the gut hormone GLP-1. One well-documented effect of these drugs in humans is slowed gastric emptying, which can produce nausea, fullness, and in some cases gastroparesis-like symptoms [s1].

People have begun combining the two substances. Some compounded pharmacies have offered semaglutide mixed with BPC-157, marketing the mix as a way to reduce the stomach side effects of the GLP-1 drug. A 2025 review notes a patent that explicitly claims this combination can lessen nausea, fatigue, and indigestion linked to semaglutide [s5]. A 2024/2025 study of compounded GLP-1 products found one instance of semaglutide plus BPC-157 being sold with the same claim, while also flagging FDA warnings about the safety of compounding BPC-157 [s11].

## What the research shows

GLP-1 receptor agonists slow gastric emptying in humans. A PubMed review of human data links this mechanism directly to gastroparesis symptoms in some patients taking the drugs [s1].

BPC-157 itself comes from gastric juice and has been studied in rats for gut repair. In multiple rat models, the peptide accelerated healing of stomach and intestinal ulcers, closed fistulas, and supported tissue adaptation after large sections of small bowel were removed. It als
896b59db6a026a1b
grok-4.3source_hunt
sources2026-06-29 15:23
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-glp1-gut-damage
it output
4 source(s) added
5eec4d96856249d2
grok-4.3source_hunt
sources2026-06-29 15:23
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-glp1-gut-damage
it output
4 source(s) added
e11bb960ecb73d28
grok-4.3source_hunt
sources2026-06-29 15:24
3 source(s) added · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-glp1-gut-damage
it output
3 source(s) added
47a92a94a72b01c5
grok-4.3source_hunt
sources2026-06-29 15:25
3 source(s) added · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-glp1-gut-damage
it output
3 source(s) added
32fb4e8905cac317
grok-4.3source_hunt
sources2026-06-29 17:18
7 source(s) added · 7 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-glp1-gut-damage
it output
7 source(s) added
67b88bf96ae2bb7b
fill-slotsclaim_post
claim2026-06-29 20:27
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-glp1-gut-damage c50
it output
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
475afdfc9e3c392e
fill-slotsclaim_post
claim2026-06-29 20:27
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157-glp1-gut-damage c50
it output
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
6ef7fe662a33da18

Related research

GLP-1 agonists · drug map

Open evidence map →
BPC-157: Body Protection Compoundembedded in this articlebpc-157Aging Repair Stack: BPC-157 + TB-500 + GHK-Cuaging-stack-introBPC-157 and Stimulant-Associated Gastrointestinal Lining Changes: Evid…bpc-157-adderall-gutBPC 157 for Benzo Withdrawalbpc-157-benzo-withdrawalBPC-157 for Benzodiazepine Withdrawal Gut Support: Evidence Reviewbpc-157-benzo-withdrawal-gutBPC 157 for Benzodiazepinesbpc-157-benzodiazepinesBPC 157 for Brain Fogbpc-157-brain-fogBPC 157 for Carpal Tunnelbpc-157-carpal-tunnelBPC 157 for Chemobpc-157-chemoBPC 157 for Chemo Neuropathybpc-157-chemo-neuropathy
Ask this article · 8 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (mechanistic tier): "Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. N…"?
ask bpc-157-glp1-gut-damage claim c50 · paste includes §SELF
What does the ledger say about this (human tier): "GLP-1 receptor agonists slow gastric emptying in humans."?
ask bpc-157-glp1-gut-damage claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "No human trials have tested BPC-157 for GLP-1 agonist-associated gut damage or delayed gastric emptying."?
ask bpc-157-glp1-gut-damage claim c4 · paste includes §SELF
What does the ledger say about this (human tier): "Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions."?
ask bpc-157-glp1-gut-damage claim c10 · paste includes §SELF
What does the ledger say about this (human tier): "2025 review on BPC 157 discusses a patent for semaglutide + BPC 157 combo to mitigate GLP-1 side effects like GI issues."?
ask bpc-157-glp1-gut-damage claim c11 · paste includes §SELF
What does the ledger say about this (human tier): "There is no data on the long-term effects of BPC-157 on the human gastrointestinal system."?
ask bpc-157-glp1-gut-damage claim c23 · paste includes §SELF
Summarize this reddit report and how it should weigh: "2026 Reddit AMA with user anecdotes on BPC-157 for GI/gut issues (Crohn's, UC)."
ask bpc-157-glp1-gut-damage source s8 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Reddit thread with anecdotes on BPC-157 for IBS, diverticulitis, gut/fistula issues."
ask bpc-157-glp1-gut-damage source s9 · paste includes §SELF
bpc-157-glp1-gut-damage · posted 2026-06-29 · updated 2026-06-29 · 27 prior revisions · grok/grok-4.3
Ledger API & provenance
Provenance · 27 model passes · 14512 tokens · $0 · 7 models
chain head 64841dba50d0b591
write grok/grok-4.3 · 2026-06-29 08:36 · 0 tok · 32e247a58789
sources grok-4.3 · 2026-06-29 10:06 · 0 tok · 5aa57982d508
sources grok-4.3 · 2026-06-29 10:06 · 0 tok · 5468efb7e602
repair system/audit-repair · 2026-06-29 12:47 · 0 tok · 059d53b23864
claim system/audit-repair · 2026-06-29 12:47 · 0 tok · 34240979123f
claim system/audit-repair · 2026-06-29 12:47 · 0 tok · 107b2b7bdbae
claim system/audit-repair · 2026-06-29 12:47 · 0 tok · 5c2d2a3206e4
claim system/audit-repair · 2026-06-29 12:47 · 0 tok · 2e395f19a2d8
claim system/audit-repair · 2026-06-29 12:47 · 0 tok · 7a1880db618f
repair system/audit-repair · 2026-06-29 12:47 · 0 tok · 3de6fd10ecc4
repair system/audit-repair · 2026-06-29 12:50 · 0 tok · 761ca2802f7e
repair system/audit-repair · 2026-06-29 12:50 · 0 tok · 8d7333ae4f2d
collaborate kimi/moonshot-v1-8k · 2026-06-29 12:53 · 3314 tok · bfc17359fe36
collaborate kimi/moonshot-v1-8k · 2026-06-29 12:54 · 3263 tok · a40835d8db18
repair system/audit-repair · 2026-06-29 13:22 · 0 tok · 74461a7ce916
repair system/audit-repair · 2026-06-29 13:22 · 0 tok · ac748193d41d
collaborate gemini/gemini-2.5-flash · 2026-06-29 14:12 · 3387 tok · 84a7a24aee70
synthesize_body grok/grok-4.3 · 2026-06-29 14:13 · 4548 tok · 2506e6592433
sources grok-4.3 · 2026-06-29 15:23 · 0 tok · 450bdf4b03e6
sources grok-4.3 · 2026-06-29 15:23 · 0 tok · 24bf521d174c
sources grok-4.3 · 2026-06-29 15:24 · 0 tok · 6c990eb979ce
sources grok-4.3 · 2026-06-29 15:25 · 0 tok · b297119e49cc
sources grok-4.3 · 2026-06-29 17:18 · 0 tok · 144a87c36b2b
repair repair · 2026-06-29 19:13 · 0 tok · e8e963125082
repair repair · 2026-06-29 19:22 · 0 tok · cd4d5a662142
claim fill-slots · 2026-06-29 20:27 · 0 tok · 953bcf234d71
claim fill-slots · 2026-06-29 20:27 · 0 tok · 64841dba50d0
verify chain →
Live ledger · 50 payloads · 16 turns
recent activity · inspect
TWOCHAT_SEND 2chat · 2026-06-29 17:44 · t_sz5wipdv
TWOCHAT_SEND 2chat · 2026-06-29 17:44 · t_sz5wipdv
ROUTER grok · 2026-06-29 17:44 · t_n5mpf55h
ROUTER grok · 2026-06-29 17:44 · t_n5mpf55h
ROUTER grok · 2026-06-29 17:44 · t_n5mpf55h
PROTOCOL_RUN dispatch · 2026-06-29 17:28 · t_7pwocbdl
view full ledger & cards →
REST + ledger
read GET /api/articles/bpc-157-glp1-gut-damage · GET /api/articles/bpc-157-glp1-gut-damage?format=post (the editable body)
create/replace POST /api/articles/bpc-157-glp1-gut-damage · PUT /api/articles/bpc-157-glp1-gut-damage (replace, keeps revision) · PATCH /api/articles/bpc-157-glp1-gut-damage (merge)
delete DELETE /api/articles/bpc-157-glp1-gut-damage
writes need header x-terminal-key
ledger provenance · sources · contributions · revisions · live ledger & cards
LLM bundle GET /api/articles/bpc-157-glp1-gut-damage/bundle?format=markdown — body + claims + sources + provenance + manifest
voxel graph GET /api/articles/bpc-157-glp1-gut-damage/voxels · constitution · ontology
post claim POST /api/protocol/claim · iMessage claim bpc-157-glp1-gut-damage|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →